STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand ...
STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand ...
As of 5:00:52 p.m. GMT+1. Market Open. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Compare up to three stocks to (KDEV-BTA-B.ST) by adding the symbol or company name.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Swedish life sciences investor Karolinska Development (Nasdaq Stockholm: KDEV) says its portfolio company SVF Vaccines has agreed a reverse acquisition with Novakand Pharma (Nasdaq First North: NOVKAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results